How trendy ‘whole-body’ scans can miss this serious illness
How trendy ‘whole-body’ scans can miss this serious illness
The tests can provide a false sense of security that leaves patients at risk.
[Photo: S.Siam/Adobe Stock]
The rise of full-body MRI scans has been framed as a victory for consumer empowerment. Skip the referrals. Skip the waiting. Pay out of pocket and finally see what is happening inside your body, before it’s too late.
For many, especially women, these scans are compelling. They offer agency in a healthcare system that often feels slow, dismissive, and reactive, rather than preventive. What many women would be surprised to learn, however, is despite the name, many full-body MRI scans do not reliably screen for breast cancer, the most common cancer in women.
Women make roughly 80% of healthcare purchasing decisions in the United States. They spend more out of pocket than men and are significantly more likely to engage in preventive care, before symptoms appear. Women are also, ironically, the same population driving the growth of direct-to-consumer healthcare, from blood testing and longevity clinics to wearables and these “full-body” scans.
The assumption most consumers make is simple. If a scan purports to image the entire body, it must include the breasts. These scans assess the brain, spine, liver, kidneys, and reproductive organs. These scans may produce reports that say everything looks normal. They may even use language like “all clear.”
What they cannot do, in many cases, is detect early breast cancer.
This is not a subtle technical nuance. Breast-specific MRI requires precise conditions to be effective: dedicated breast coils, prone positioning, contrast enhancement, and high spatial resolution. Full body MRI scans are optimized for speed and coverage, not for the detailed imaging that breast tissue requires. As a result, these scans can miss small or early lesions, particularly in dense breasts, which affect nearly half of all women over 40 and are common in younger women.
Radiologists understand this distinction. The companies selling these scans are aware of this as well, and they even include this disclosure in the fine print. However, the average consumer often isn’t aware.
Claire's went from tween mall icon to bankrupt — twice?
